|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
By Industry | By Industry Segment | By Services and Suppliers
| By Location
| By Hotbed |
Profile Search
|
Vaxart, Inc.
600 Townsend Street
Suite 120E
San Francisco
California
94103
U.S.A.
Phone:
415-437-0132
Fax:
|
|
|
Company News |
Vaxart, Inc. Begins First Oral Vaccine Clinical Trial
6/7/2011 11:14:11 AM
More...
|
Vaxart, Inc. Raises $12.5 Million Series B
3/4/2010 7:43:56 AM
More...
|
Vaxart, Inc. Awarded National Institutes of Health (NIH) Grant to Support Development of Orally-Delivered H5N1 Avian Influenza Vaccine
9/8/2009 10:31:03 AM
More...
|
Vaxart, Inc. Begins Animal Testing of H1N1 Flu Vaccine Candidate
5/26/2009 8:51:35 AM
More...
|
Vaxart, Inc. Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies
10/24/2008 8:16:22 AM
More...
|
Robert Fildes, Former President of Biogen Idec, Inc. (Massachusetts) (BIIB) and Cetus, Joins Vaxart, Inc. Board
3/18/2008 10:07:12 AM
More...
|
Vaxart, Inc. Completes Series A Financing
11/15/2007 2:55:00 PM
More...
|
|
|
 |
|
|
|
|
|
|
|
|
|